Lifeist Wellness Inc. (LFST.V)
CAD 0.04
(-12.5%)
CAD 0.04
(-12.5%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -12.24 Million CAD | 19.3% |
| 2022 | -15.56 Million CAD | 32.14% |
| 2021 | -22.92 Million CAD | 11.79% |
| 2020 | -25.99 Million CAD | -608.42% |
| 2019 | 5.11 Million CAD | 120.91% |
| 2018 | -24.44 Million CAD | -34.85% |
| 2017 | -18.12 Million CAD | -1458.08% |
| 2016 | -1.16 Million CAD | -276.22% |
| 2015 | 660.31 Thousand CAD | 197.52% |
| 2014 | -677.09 Thousand CAD | -93.36% |
| 2013 | -350.17 Thousand CAD | 17.99% |
| 2012 | -426.99 Thousand CAD | 45.73% |
| 2011 | -786.84 Thousand CAD | -76.19% |
| 2010 | -446.58 Thousand CAD | -157.28% |
| 2009 | -173.58 Thousand CAD | -41.4% |
| 2008 | -122.76 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.5 Million CAD | 133.9% |
| 2024 Q3 | -1.18 Million CAD | -162.53% |
| 2024 Q2 | 1.9 Million CAD | 26.67% |
| 2023 Q3 | -2.35 Million CAD | 10.47% |
| 2023 Q2 | -2.62 Million CAD | 18.96% |
| 2023 Q1 | -3.23 Million CAD | 22.18% |
| 2023 FY | -12.55 Million CAD | 19.3% |
| 2023 Q4 | -4.42 Million CAD | -88.25% |
| 2022 Q4 | -4.16 Million CAD | -82.13% |
| 2022 Q2 | -4.85 Million CAD | -3.24% |
| 2022 Q1 | -4.7 Million CAD | -12.31% |
| 2022 FY | -15.56 Million CAD | 32.14% |
| 2022 Q3 | -2.28 Million CAD | 52.91% |
| 2021 Q4 | -4.18 Million CAD | 28.82% |
| 2021 Q2 | -6.04 Million CAD | 4.52% |
| 2021 Q1 | -6.32 Million CAD | 17.64% |
| 2021 FY | -22.92 Million CAD | 11.79% |
| 2021 Q3 | -5.88 Million CAD | 2.68% |
| 2020 Q2 | -5.89 Million CAD | 12.86% |
| 2020 Q1 | -6.75 Million CAD | -121.64% |
| 2020 Q3 | -4.54 Million CAD | 22.78% |
| 2020 Q4 | -7.68 Million CAD | -68.96% |
| 2020 FY | -25.99 Million CAD | -608.42% |
| 2019 Q3 | -6.38 Million CAD | 28.56% |
| 2019 Q1 | -10.37 Million CAD | 20.35% |
| 2019 Q2 | -8.93 Million CAD | 13.8% |
| 2019 Q4 | 31.23 Million CAD | 589.06% |
| 2019 FY | 5.11 Million CAD | 120.91% |
| 2018 Q1 | -3.5 Million CAD | -11.47% |
| 2018 FY | -24.44 Million CAD | -34.85% |
| 2018 Q4 | -13.02 Million CAD | -39.42% |
| 2018 Q3 | -9.33 Million CAD | -200.94% |
| 2018 Q2 | 9.25 Million CAD | 364.12% |
| 2017 Q2 | -4.4 Million CAD | -183.46% |
| 2017 Q1 | -1.55 Million CAD | -81.1% |
| 2017 FY | -18.12 Million CAD | -1458.08% |
| 2017 Q4 | -3.14 Million CAD | 74.02% |
| 2017 Q3 | -12.09 Million CAD | -174.66% |
| 2016 Q4 | -857.76 Thousand CAD | 1.32% |
| 2016 Q2 | -363.49 Thousand CAD | 36.56% |
| 2016 FY | -1.16 Million CAD | -276.22% |
| 2016 Q1 | -572.96 Thousand CAD | -873.22% |
| 2016 Q3 | -869.24 Thousand CAD | -139.14% |
| 2015 FY | 660.31 Thousand CAD | 197.52% |
| 2015 Q4 | -58.87 Thousand CAD | -112.8% |
| 2015 Q3 | -27.66 Thousand CAD | 42.16% |
| 2015 Q2 | -47.83 Thousand CAD | 77.45% |
| 2015 Q1 | -212.08 Thousand CAD | -63.4% |
| 2014 Q4 | -129.79 Thousand CAD | 50.66% |
| 2014 FY | -677.09 Thousand CAD | -93.36% |
| 2014 Q3 | -263.07 Thousand CAD | -29.06% |
| 2014 Q1 | -156.63 Thousand CAD | -164.5% |
| 2014 Q2 | -203.84 Thousand CAD | -30.14% |
| 2013 Q4 | -59.22 Thousand CAD | 13.79% |
| 2013 FY | -350.17 Thousand CAD | 17.99% |
| 2013 Q1 | -84.27 Thousand CAD | -4.21% |
| 2013 Q2 | -65.67 Thousand CAD | 22.07% |
| 2013 Q3 | -68.68 Thousand CAD | -4.59% |
| 2012 Q4 | -80.86 Thousand CAD | 28.93% |
| 2012 Q1 | -223.67 Thousand CAD | -18.82% |
| 2012 FY | -426.99 Thousand CAD | 45.73% |
| 2012 Q3 | -113.78 Thousand CAD | 23.58% |
| 2012 Q2 | -148.88 Thousand CAD | 33.44% |
| 2011 Q1 | -233.92 Thousand CAD | -347.12% |
| 2011 Q3 | -236.35 Thousand CAD | -70.54% |
| 2011 FY | -786.84 Thousand CAD | -76.19% |
| 2011 Q2 | -138.58 Thousand CAD | 40.75% |
| 2011 Q4 | -188.23 Thousand CAD | 20.36% |
| 2010 FY | -446.58 Thousand CAD | -157.28% |
| 2010 Q3 | -94.75 Thousand CAD | -44.48% |
| 2010 Q2 | -65.58 Thousand CAD | -64.51% |
| 2010 Q1 | -39.86 Thousand CAD | -5.31% |
| 2010 Q4 | -52.31 Thousand CAD | 44.79% |
| 2009 FY | -173.58 Thousand CAD | -41.4% |
| 2009 Q3 | -45.67 Thousand CAD | -65.99% |
| 2009 Q4 | -37.85 Thousand CAD | 17.11% |
| 2009 Q2 | -27.51 Thousand CAD | 83.77% |
| 2009 Q1 | -169.55 Thousand CAD | -169.9% |
| 2008 FY | -122.76 Thousand CAD | 0.0% |
| 2008 Q4 | 242.58 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.82 Million CAD | -334.353% |
| CanadaBis Capital Inc. | 4.67 Million CAD | 361.926% |
| Decibel Cannabis Company Inc. | 1.41 Million CAD | 967.564% |
| Delivra Health Brands Inc. | -710 Thousand CAD | -1625.352% |
| Entourage Health Corp. | -21.37 Million CAD | 42.698% |
| Cannara Biotech Inc. | 11.88 Million CAD | 203.047% |
| Medicure Inc. | -854 Thousand CAD | -1334.426% |
| PharmaCielo Ltd. | -9.7 Million CAD | -26.276% |
| Rubicon Organics Inc. | -1.08 Million CAD | -1030.653% |
| BioSyent Inc. | 7.47 Million CAD | 263.964% |
| Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | -903.315% |